Canadian Sec - Free Realtime Quote CAD

InnoCan Pharma Corporation (INNO.CN)

0.1600
-0.0100
(-5.88%)
As of 9:49:15 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
29,437
29,437
--
2,559
196
Cost of Revenue
3,250
3,250
--
452
75
Gross Profit
26,187
26,187
--
2,107
121
Operating Expense
27,434
27,434
--
8,373
7,601
Operating Income
-1,247
-1,247
--
-6,266
-7,480
Net Non Operating Interest Income Expense
-7
-7
--
19
-13
Other Income Expense
2,173
2,173
--
2,359
-2,598
Pretax Income
919
919
--
-3,888
-10,091
Tax Provision
1,181
1,181
--
1
0
Net Income Common Stockholders
-1,834
-1,834
--
-3,764
-10,047
Diluted NI Available to Com Stockholders
-1,834
-1,834
--
-3,764
-10,047
Basic EPS
-0.01
-0.01
-0.02
-0.02
-0.05
Diluted EPS
-0.01
-0.01
-0.02
-0.02
-0.05
Basic Average Shares
280,040.8420
280,040.8420
257,003.7750
248,953.2200
224,541.7800
Diluted Average Shares
280,040.8420
280,040.8420
257,003.7750
248,953.2200
224,541.7800
Total Operating Income as Reported
-1,247
-1,247
--
-6,266
-7,480
Rent Expense Supplemental
--
--
--
198
84
Total Expenses
30,684
30,684
--
8,825
7,676
Net Income from Continuing & Discontinued Operation
-1,834
-1,834
--
-3,764
-10,047
Normalized Income
-3,681.0500
-3,681.0500
--
-5,504.7061
-7,449
Interest Income
0
0
--
21
--
Interest Expense
7
7
--
2
13
Net Interest Income
-7
-7
--
19
-13
EBIT
926
926
--
-3,886
-10,078
EBITDA
961
961
--
-3,851
-10,035
Reconciled Cost of Revenue
3,250
3,250
--
452
75
Reconciled Depreciation
35
35
--
35
43
Net Income from Continuing Operation Net Minority Interest
-1,834
-1,834
--
-3,764
-10,047
Total Unusual Items Excluding Goodwill
2,173
2,173
--
2,359
-2,598
Total Unusual Items
2,173
2,173
--
2,359
-2,598
Normalized EBITDA
-1,212
-1,212
--
-6,210
-7,437
Tax Rate for Calcs
0.0002
0.0002
--
0.0003
0
Tax Effect of Unusual Items
325.9500
325.9500
--
618.2939
0
12/31/2021 - 9/25/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CTX.TO Crescita Therapeutics Inc.
0.5200
-1.89%
 
VEXT.CN Vext Science, Inc.
0.1100
0.00%
 
TILT.NE TILT Holdings Inc.
0.0100
0.00%
 
AAWH-U.CN Ascend Wellness Holdings, Inc.
0.3300
-2.94%
 
IMCC.CN IM Cannabis Corp.
2.2700
-3.40%
 
ETST Earth Science Tech, Inc.
0.1445
+0.35%
 
MEDXF Medexus Pharmaceuticals Inc.
1.8540
-1.38%
 
ROMJ.V Rubicon Organics Inc.
0.4000
-1.23%
 
AVCN.TO Avicanna Inc.
0.2400
-4.00%
 
CPHRF Cipher Pharmaceuticals Inc.
9.27
-0.11%